People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Other Health Care, Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VytronUS Inc | — | Other Health Care | Series B | $91.1M | $664.6M | 2009 |
| Alessa Therapeutics, Inc. | — | Pharma | Series B | $31.6M | $129.5M | 2019 |
| Mirimus, Inc. | — | Biotechnology | Seed | $2.0M | $88.8M | 2011 |
John Maroney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Maroney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Lim | 1 | 14 |
| John Nehra | 1 | 11 |
| Douglas Crawford | 1 | 8 |
| Peter Justin Klein | 1 | 7 |
| Cam Gallagher | 1 | 7 |
| Roy Tanaka | 1 | 6 |
| Peter Parker | 1 | 6 |
| Leo - Guthart | 1 | 4 |
| John Pavlidis | 1 | 4 |
| Zachary Collins | 1 | 3 |
| A. Jay Graf | 1 | 3 |
| Doug Crawford | 1 | 3 |
| Annie Mitsak | 1 | 2 |
| Michael Pederson | 1 | 2 |
| Steve Tregay | 1 | 2 |
| Steven Winick | 1 | 2 |
| Prem Premsrirut | 1 | 1 |
| David Gallup | 1 | 1 |
| Justin Jay Klein | 1 | 1 |
| Roy Jay Tanaka | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.